+データを開く
-基本情報
登録情報 | データベース: PDB / ID: 2j7q | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
タイトル | Crystal structure of the ubiquitin-specific protease encoded by murine cytomegalovirus tegument protein M48 in complex with a ubquitin-based suicide substrate | |||||||||
要素 |
| |||||||||
キーワード | HYDROLASE / HERPESVIRIDAE / NUCLEAR PROTEIN / COVALENT ENZYME-LIGAND COMPLEX / DEUBIQUITINATING ENZYME / PAPAIN-LIKE FOLD / CYSTEINE PROTEASE | |||||||||
機能・相同性 | 機能・相同性情報 : / : / protein modification process => GO:0036211 / Peptide chain elongation / Selenocysteine synthesis / Formation of a pool of free 40S subunits / Eukaryotic Translation Termination / Response of EIF2AK4 (GCN2) to amino acid deficiency / SRP-dependent cotranslational protein targeting to membrane / Viral mRNA Translation ...: / : / protein modification process => GO:0036211 / Peptide chain elongation / Selenocysteine synthesis / Formation of a pool of free 40S subunits / Eukaryotic Translation Termination / Response of EIF2AK4 (GCN2) to amino acid deficiency / SRP-dependent cotranslational protein targeting to membrane / Viral mRNA Translation / Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) / GTP hydrolysis and joining of the 60S ribosomal subunit / L13a-mediated translational silencing of Ceruloplasmin expression / Major pathway of rRNA processing in the nucleolus and cytosol / Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) / Maturation of protein E / Maturation of protein E / ER Quality Control Compartment (ERQC) / Myoclonic epilepsy of Lafora / IRAK2 mediated activation of TAK1 complex / Alpha-protein kinase 1 signaling pathway / FLT3 signaling by CBL mutants / Prevention of phagosomal-lysosomal fusion / IRAK1 recruits IKK complex / IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation / Glycogen synthesis / IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation / TICAM1,TRAF6-dependent induction of TAK1 complex / Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 / Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation / Membrane binding and targetting of GAG proteins / Endosomal Sorting Complex Required For Transport (ESCRT) / Negative regulation of FLT3 / Constitutive Signaling by NOTCH1 HD Domain Mutants / PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 / TICAM1-dependent activation of IRF3/IRF7 / NOTCH2 Activation and Transmission of Signal to the Nucleus / cytosolic ribosome / Regulation of FZD by ubiquitination / APC/C:Cdc20 mediated degradation of Cyclin B / p75NTR recruits signalling complexes / VLDLR internalisation and degradation / Downregulation of ERBB4 signaling / TRAF6-mediated induction of TAK1 complex within TLR4 complex / TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling / APC-Cdc20 mediated degradation of Nek2A / Regulation of innate immune responses to cytosolic DNA / InlA-mediated entry of Listeria monocytogenes into host cells / NF-kB is activated and signals survival / Regulation of pyruvate metabolism / Downregulation of ERBB2:ERBB3 signaling / NRIF signals cell death from the nucleus / Pexophagy / Regulation of PTEN localization / Regulation of BACH1 activity / Activated NOTCH1 Transmits Signal to the Nucleus / Synthesis of active ubiquitin: roles of E1 and E2 enzymes / Translesion synthesis by REV1 / TICAM1, RIP1-mediated IKK complex recruitment / MAP3K8 (TPL2)-dependent MAPK1/3 activation / Translesion synthesis by POLK / Downregulation of TGF-beta receptor signaling / Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) / Translesion synthesis by POLI / JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 / Gap-filling DNA repair synthesis and ligation in GG-NER / IKK complex recruitment mediated by RIP1 / InlB-mediated entry of Listeria monocytogenes into host cell / Regulation of activated PAK-2p34 by proteasome mediated degradation / Josephin domain DUBs / PINK1-PRKN Mediated Mitophagy / TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) / N-glycan trimming in the ER and Calnexin/Calreticulin cycle / TNFR1-induced NF-kappa-B signaling pathway / Autodegradation of Cdh1 by Cdh1:APC/C / APC/C:Cdc20 mediated degradation of Securin / TCF dependent signaling in response to WNT / SCF-beta-TrCP mediated degradation of Emi1 / Asymmetric localization of PCP proteins / NIK-->noncanonical NF-kB signaling / Regulation of NF-kappa B signaling / Ubiquitin-dependent degradation of Cyclin D / activated TAK1 mediates p38 MAPK activation / AUF1 (hnRNP D0) binds and destabilizes mRNA / TNFR2 non-canonical NF-kB pathway / Regulation of signaling by CBL / Vpu mediated degradation of CD4 / Negative regulators of DDX58/IFIH1 signaling / NOTCH3 Activation and Transmission of Signal to the Nucleus / Assembly of the pre-replicative complex / Degradation of DVL / Deactivation of the beta-catenin transactivating complex / Ubiquitin Mediated Degradation of Phosphorylated Cdc25A / Dectin-1 mediated noncanonical NF-kB signaling / Cdc20:Phospho-APC/C mediated degradation of Cyclin A / Fanconi Anemia Pathway / Iron uptake and transport / Negative regulation of FGFR2 signaling / Negative regulation of FGFR3 signaling / Hh mutants are degraded by ERAD 類似検索 - 分子機能 | |||||||||
生物種 | MURINE CYTOMEGALOVIRUS (ヘルペスウイルス) HOMO SAPIENS (ヒト) | |||||||||
手法 | X線回折 / シンクロトロン / 単波長異常分散 / 解像度: 1.8 Å | |||||||||
データ登録者 | Schlieker, C. / Weihofen, W.A. / Frijns, E. / Kattenhorn, L.M. / Gaudet, R. / Ploegh, H.L. | |||||||||
引用 | ジャーナル: Mol.Cell / 年: 2007 タイトル: Structure of a Herpesvirus-Encoded Cysteine Protease Reveals a Unique Class of Deubiquitinating Enzymes 著者: Schlieker, C. / Weihofen, W.A. / Frijns, E. / Kattenhorn, L.M. / Gaudet, R. / Ploegh, H.L. | |||||||||
履歴 |
| |||||||||
Remark 700 | SHEET THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN ORDER TO REPRESENT THIS FEATURE IN ... SHEET THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, TWO SHEETS ARE DEFINED. |
-構造の表示
構造ビューア | 分子: MolmilJmol/JSmol |
---|
-ダウンロードとリンク
-ダウンロード
PDBx/mmCIF形式 | 2j7q.cif.gz | 152.2 KB | 表示 | PDBx/mmCIF形式 |
---|---|---|---|---|
PDB形式 | pdb2j7q.ent.gz | 118.8 KB | 表示 | PDB形式 |
PDBx/mmJSON形式 | 2j7q.json.gz | ツリー表示 | PDBx/mmJSON形式 | |
その他 | その他のダウンロード |
-検証レポート
文書・要旨 | 2j7q_validation.pdf.gz | 473.4 KB | 表示 | wwPDB検証レポート |
---|---|---|---|---|
文書・詳細版 | 2j7q_full_validation.pdf.gz | 476.6 KB | 表示 | |
XML形式データ | 2j7q_validation.xml.gz | 31.8 KB | 表示 | |
CIF形式データ | 2j7q_validation.cif.gz | 48.2 KB | 表示 | |
アーカイブディレクトリ | https://data.pdbj.org/pub/pdb/validation_reports/j7/2j7q ftp://data.pdbj.org/pub/pdb/validation_reports/j7/2j7q | HTTPS FTP |
-関連構造データ
関連構造データ | |
---|---|
類似構造データ |
-リンク
-集合体
登録構造単位 |
| ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 |
| ||||||||||||
2 |
| ||||||||||||
単位格子 |
| ||||||||||||
非結晶学的対称性 (NCS) | NCS oper:
|
-要素
-MCMV TEGUMENT PROTEIN M48 ENCODED UBIQUITIN- SPECIFIC PROTEASE, ... , 2種, 2分子 AC
#1: タンパク質 | 分子量: 25677.289 Da / 分子数: 1 / 由来タイプ: 組換発現 詳細: DEUBIQUITINATING MODULE OF MURINE CYTOMEGALOVIRUS TEGUMENT PROTEIN M48. ACTIVE SITE CYSTEINE 23 IS COVALENTLY LINKED TO THE FORMER VINYLMETHYLESTER MOIETY OF THE SUICIDE SUBSTATE UBVME 由来: (組換発現) MURINE CYTOMEGALOVIRUS (ヘルペスウイルス) 株: MCMV STRAIN SMITH / プラスミド: PET28 (NOVAGEN) / 発現宿主: ESCHERICHIA COLI (大腸菌) / 株 (発現宿主): BL21(DE3) |
---|---|
#3: タンパク質 | 分子量: 25686.316 Da / 分子数: 1 / 由来タイプ: 組換発現 詳細: DEUBIQUITINATING MODULE OF MURINE CYTOMEGALOVIRUS TEGUMENT PROTEIN M48. ACTIVE SITE CYSTEINE 23 IS COVALENTLY LINKED TO THE FORMER VINYLMETHYLESTER MOIETY OF THE SUICIDE SUBSTATE UBVME 由来: (組換発現) MURINE CYTOMEGALOVIRUS (ヘルペスウイルス) 株: MCMV STRAIN SMITH / プラスミド: PET28 (NOVAGEN) / 発現宿主: ESCHERICHIA COLI (大腸菌) / 株 (発現宿主): BL21(DE3) |
-タンパク質 , 1種, 2分子 BD
#2: タンパク質 | 分子量: 8519.778 Da / 分子数: 2 Fragment: UBIQUITIN FUSED TO VINYLMETHYLESTER, UBVME, RESIDUES 1-75 由来タイプ: 組換発現 詳細: THE C-TERMINAL GLY 76 IS REPLACED BY THE VINYLMETHYLESTER MOIETY 由来: (組換発現) HOMO SAPIENS (ヒト) / プラスミド: PTYB (NEW ENGLAND BIOLABS) / 発現宿主: ESCHERICHIA COLI (大腸菌) / 株 (発現宿主): BL21(DE3) / 参照: UniProt: P62988, UniProt: P0CG48*PLUS |
---|
-非ポリマー , 5種, 714分子
#4: 化合物 | #5: 化合物 | #6: 化合物 | ChemComp-PG4 / | #7: 化合物 | ChemComp-GOL / | #8: 水 | ChemComp-HOH / | |
---|
-実験情報
-実験
実験 | 手法: X線回折 / 使用した結晶の数: 1 |
---|
-試料調製
結晶 | マシュー密度: 1.95 Å3/Da / 溶媒含有率: 36.49 % |
---|---|
結晶化 | pH: 7.5 / 詳細: 200 MM MAGNESIUM FORMATE, 14% PEG 3350, pH 7.50 |
-データ収集
回折 | 平均測定温度: 100 K |
---|---|
放射光源 | 由来: シンクロトロン / サイト: APS / ビームライン: 24-ID-C / 波長: 0.9797 |
検出器 | タイプ: ADSC CCD / 検出器: CCD / 日付: 2006年3月31日 |
放射 | モノクロメーター: SI 111 / プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
放射波長 | 波長: 0.9797 Å / 相対比: 1 |
反射 | 解像度: 1.8→50 Å / Num. obs: 52323 / % possible obs: 97.4 % / Observed criterion σ(I): 2 / 冗長度: 4.2 % / Rmerge(I) obs: 0.09 / Net I/σ(I): 8.3 |
反射 シェル | 解像度: 1.8→1.86 Å / 冗長度: 2.4 % / Rmerge(I) obs: 0.27 / Mean I/σ(I) obs: 3.5 / % possible all: 84.2 |
-解析
ソフトウェア |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 構造決定の手法: 単波長異常分散 / 解像度: 1.8→50 Å / Cor.coef. Fo:Fc: 0.96 / Cor.coef. Fo:Fc free: 0.925 / SU B: 4.84 / SU ML: 0.079 / TLS residual ADP flag: LIKELY RESIDUAL / 交差検証法: THROUGHOUT / ESU R: 0.123 / ESU R Free: 0.128 / 立体化学のターゲット値: MAXIMUM LIKELIHOOD / 詳細: HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
溶媒の処理 | イオンプローブ半径: 0.8 Å / 減衰半径: 0.8 Å / VDWプローブ半径: 1.4 Å / 溶媒モデル: MASK | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
原子変位パラメータ | Biso mean: 10.21 Å2
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化ステップ | サイクル: LAST / 解像度: 1.8→50 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
拘束条件 |
|